Risk assessment in cancer patients with fever and neutropenia: a prospective, two-center validation of a prediction rule.

作者: J A Talcott , R D Siegel , R Finberg , L Goldman

DOI: 10.1200/JCO.1992.10.2.316

关键词:

摘要: PURPOSEThe study was undertaken to validate a clinical model for predicting the medical risk of cancer patients with fever and neutropenia.PATIENTS AND METHODSA consecutive sample 444 neutropenia (granulocyte count less than 500/microL) at two hospitals, specialized referral center university-affiliated general hospital, studied identify characteristics in first 24 hours that predict subsequent serious complications during hospital stay. To control bias, major factors were subject blinded review.RESULTSSerious occurred 34% identified prior study, including inpatient status (group I), outpatients independent comorbidity II), or uncontrolled III), compared 5% remaining IV) (P .000001). Two group IV transient asympto...

参考文章(18)
James A. Talcott, The Medical Course of Cancer Patients With Fever and Neutropenia Archives of Internal Medicine. ,vol. 148, pp. 2561- 2568 ,(1988) , 10.1001/ARCHINTE.1988.00380120031007
Warren Balinsky, Susan Nesbitt, Cost-effectiveness of outpatient parenteral antibiotics: a review of the literature. The American Journal of Medicine. ,vol. 87, pp. 301- 305 ,(1989) , 10.1016/S0002-9343(89)80155-X
John H. Wasson, Harold C. Sox, Raymond K. Neff, Lee Goldman, Clinical prediction rules. Applications and methodological standards. The New England Journal of Medicine. ,vol. 313, pp. 793- 799 ,(1985) , 10.1056/NEJM198509263131306
Gerald P. Bodey, Steven J. Ketchel, Victorio Rodriguez, A randomized study of carbenicillin plus cefamandole or tobramycin in the treatment of febrile episodes in cancer patients The American Journal of Medicine. ,vol. 67, pp. 608- 616 ,(1979) , 10.1016/0002-9343(79)90242-0
Philip A Pizzo, Kay J Robichaud, Fred A Gill, Frank G Witebsky, Arthur S Levine, Albert B Deisseroth, Daniel L Glaubiger, James D MacLowry, Ian T Magrath, David G Poplack, Richard M Simon, Duration of empiric antibiotic therapy in granulocytopenic patients with cancer The American Journal of Medicine. ,vol. 67, pp. 194- 200 ,(1979) , 10.1016/0002-9343(79)90390-5
Stephen C. Schimpff, Overview of Empiric Antibiotic Therapy for the Febrile Neutropenic Patient Clinical Infectious Diseases. ,vol. 7, pp. S734- S740 ,(1985) , 10.1093/CLINIDS/7.SUPPLEMENT_4.S734
Elias J. Anaissie, Victor Fainstein, Gerald P. Bodey, Kenneth Rolston, Linda Elting, Hagop Kantarjian, Fernando Cabanillas, Kenneth B. McCredie, Randomized trial of beta-lactam regimens in febrile neutropenic cancer patients The American Journal of Medicine. ,vol. 84, pp. 581- 589 ,(1988) , 10.1016/0002-9343(88)90140-4